Automated quantification of posterior vitreous inflammation: optical coherence tomography scan number requirements.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 02 2021
08 02 2021
Historique:
received:
26
05
2020
accepted:
25
01
2021
entrez:
9
2
2021
pubmed:
10
2
2021
medline:
16
11
2021
Statut:
epublish
Résumé
Quantifying intraocular inflammation is crucial in managing uveitis patients. We assessed the minimum B-scan density for reliable automated vitreous intensity (VI) assessment, using a novel approach based on optical coherence tomography (OCT). OCT volume scans centered on the macula were retrospectively collected in patients with uveitis. Nine B-scans per volume scan at fixed locations were automatically analyzed. The following B-scan selections were compared against the average score of 9 B-scans per volume scan as a reference standard: 1/3/5/7 central scans (1c/3c/5c/7c), 3 widely distributed scans (3w). Image data of 49 patients (31 females) were included. The median VI was 0.029 (IQR: 0.032). The intra-class-correlation coefficient of the VI across the 9 B-scans was 0.923. The median difference from the reference standard ranged between 0.001 (7c) and 0.006 (1c). It was significantly lower for scan selection 3w than 5c, p(adjusted) = 0.022, and lower for selection 7c than 3w, p(adjusted) = 0.003. The scan selections 7c and 3w showed the two highest areas under the receiver operating curve (0.985 and 0.965, respectively). Three widely distributed B-scans are sufficient to quantify VI reliably. Highest reliability was achieved using 7 central B-scans. Automated quantification of VI in uveitis is reliable and requires only few OCT B-scans.
Identifiants
pubmed: 33558619
doi: 10.1038/s41598-021-82786-0
pii: 10.1038/s41598-021-82786-0
pmc: PMC7870671
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3271Subventions
Organisme : Wellcome Trust
ID : 200141/Z/15/Z
Pays : United Kingdom
Références
Br J Ophthalmol. 2017 Feb;101(2):175-179
pubmed: 27150826
Am J Ophthalmol. 2014 Aug;158(2):345-353.e2
pubmed: 24857688
Eur J Neurol. 2020 Jan;27(1):144-e3
pubmed: 31342606
Transl Vis Sci Technol. 2015 Sep 16;4(5):4
pubmed: 26396930
Sci Rep. 2018 Jan 26;8(1):1648
pubmed: 29374239
Ophthalmology. 2009 May;116(5):964-70
pubmed: 19410954
Retina. 2014 Jun;34(6):1163-6
pubmed: 24406389
Retina. 2019 Jan;39(1):150-156
pubmed: 29095359
Science. 1991 Nov 22;254(5035):1178-81
pubmed: 1957169
Int Ophthalmol. 2010 Oct;30(5):453-64
pubmed: 19430730
Am J Ophthalmol. 2016 Jan;161:172-80.e1-4
pubmed: 26476212
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Ocul Immunol Inflamm. 2018;26(1):2-16
pubmed: 27467180
Br J Ophthalmol. 2016 Apr;100(4):491-4
pubmed: 26261232
Acta Ophthalmol. 2012 Jun;90(4):e274-80
pubmed: 22429902
Am J Ophthalmol. 2010 Nov;150(5):637-641.e1
pubmed: 20719302
Am J Ophthalmol. 2009 Sep;148(3):431-8
pubmed: 19493524
Eye (Lond). 2017 Jan;31(1):53-61
pubmed: 27911444
J Microsc. 2012 Sep;247(3):209-19
pubmed: 22708800
Am J Ophthalmol. 2008 Dec;146(6):813-8.e1
pubmed: 18687418
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO131-BIO140
pubmed: 28655060
Ophthalmology. 2014 Sep;121(9):1706-14
pubmed: 24835759
Eye (Lond). 2011 Oct;25(10):1347-55
pubmed: 21760625
Ophthalmology. 1997 Jan;104(1):64-71; discussion 71-2
pubmed: 9022106
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1071-8
pubmed: 19797199
Eur J Ophthalmol. 2013 Sep-Oct;23(5):705-17
pubmed: 23661536